Low 25-Hydroxyvitamin D Levels Are Associated with Infections and Mortality in Patients with Cirrhosis
Open Access
- 29 June 2015
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (6) , e0132119
Abstract
Vitamin D, best known to regulate bone mineralization, has numerous additional roles including regulation inflammatory pathways. Recently, an increased incidence of 25-hydroxyvitamin D3 (25(OH)D3) deficiency has been found in subjects suffering from liver diseases. We here investigated if low vitamin D levels might be associated with prognosis, inflammation and infectious complications in patients with cirrhosis. We performed a prospective cohort study investigating the relation between 25(OH)D3 levels and stages of cirrhosis, mortality and complications of cirrhosis, including infections. 251 patients with cirrhosis were enrolled into the present prospective cohort study. 25(OH)D3 levels were quantified by radioimmunoassay from serum samples obtained at study inclusion. The mean follow-up time was 411 ± 397 days with a range of 1-1382 days. 30 (12.0%) patients underwent liver transplantation and 85 (33.8%) individuals died within the study. The mean serum 25(OH)D3 concentration was 8.93 ± 7.1 ng/ml with a range of 1.0 to 46.0 ng/ml. 25(OH)D3 levels differed significantly between Child Pugh scores and showed a negative correlation with the model of end stage liver disease (MELD) score. Patients with decompensated cirrhosis and infectious complications, had significantly lower 25(OH)D3 levels compared to subjects without complications. Low 25(OH)D3 was associated with mortality in uni- as well as multivariate Cox regression models. 25(OH)D3 deficiency is associated with advanced liver disease and low 25(OH)D3 levels are an indicator for a poor outcome and are associated with infectious complications.Keywords
This publication has 36 references indexed in Scilit:
- Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier functionJournal of Hepatology, 2013
- D-livering the message: The importance of vitamin D status in chronic liver diseaseJournal of Hepatology, 2012
- Association of 25‐hydroxyvitamin D levels with liver dysfunction and mortality in chronic liver diseaseLiver International, 2012
- The anti-cancer and anti-inflammatory actions of 1,25(OH)2D3Best Practice & Research Clinical Endocrinology & Metabolism, 2011
- Vitamin D Status and Expression of Vitamin D Receptor and LL-37 in Patients with Spontaneous Bacterial PeritonitisDigestive Diseases and Sciences, 2011
- Vitamin D deficiency in cirrhosis relates to liver dysfunction rather than aetiologyWorld Journal of Gastroenterology, 2011
- Prevalence of Vitamin D Deficiency in Chronic Liver DiseaseDigestive Diseases and Sciences, 2009
- Calcium and 1α,25‐dihydroxyvitamin D3 target the TNF‐α pathway to suppress experimental inflammatory bowel diseaseEuropean Journal of Immunology, 2004
- A Model to Predict Survival in Patients With End–Stage Liver DiseaseHepatology, 2001
- 1,25-dihydroxyvitamin D3 inhibits cytokine production by human blood monocytes at the post-transcriptional levelCytokine, 1992